Roche Diagnostics Middle East FZCO has set a new milestone as the first in-vitro diagnostics company in the Middle East to secure the prestigious ISO27001 Information Security certification in recognition of its exceptional commitment to protecting patient data information and building trust across the region.
The certification was awarded following a rigorous evaluation process of its information security management systems and operations.
ISO 27001 is an internationally accepted information security standard. It identifies the requirements for a comprehensive Information Security Management System (ISMS) and defines how organisations should manage and handle information in a secure manner, including appropriate security controls. It is universally recognised as a critical tool for assisting organisations in managing multiple threats and safeguarding their information assets.
Roche follows global best practices in information security by meeting the stringent criteria set under the ISO 27001 protocols. By aligning with international standards and having a structured method to address compliance requirements, Roche Diagnostics Middle East has achieved proven results in reducing the chances of security breaches and gained the increased trust and respect of its partners, customers and the public.
With combined strengths in both diagnostics and pharmaceuticals, Roche makes significant contributions to the healthcare system. 2022 is special for Roche, which celebrates its 125th anniversary, as well as the tenth anniversary of Roche Diagnostics Middle East.
Click below to share this article